Filip Søskov Davidovski

Filip Søskov Davidovski is a Medical Doctor, Research Fellow, and PhD student at the University of Copenhagen's Faculty of Health and Medical Sciences, Department of Biomedical Sciences. His research focuses on cardiovascular physiology, kidney, and lung function, with emphasis on vaccine efficacy in elderly populations through major clinical trials including DANFLU-2 and DAN-RSV.

Education:

• Master's in Public Health (MPH), Imperial College London (Expected 2026)
• Doctor of Medicine (MD), University of Copenhagen (2022)

Davidovski's work bridges cardiovascular medicine and infectious disease vaccinology, investigating how influenza and RSV vaccines impact hospitalization rates and cardiovascular outcomes in older adults. His research leverages large-scale clinical trials to translate findings into public health strategies for vulnerable populations, with strong international collaborations across Europe and North America.

Analysis of his 2025 publications reveals a concentrated focus on two landmark trials: DANFLU-2 (influenza vaccine dosing) and DAN-RSV (RSV vaccine cardiovascular effects), demonstrating significant reductions in hospitalizations and establishing vaccination as a key preventive strategy for cardiovascular complications in aging populations.

Scientific Awards:

• The OSVAL award (2021)

Davidovski actively contributes to medical education through his national-recognized podcast "Filip's Medical Podcast" (since 2020) and lecturing roles at DIS Study Abroad and the University of Copenhagen. He serves on multiple governance boards including the Research Council at Copenhagen University Hospital - Herlev and Gentofte and the Institute for Clinical Medicine board.

As a core member of the Physiology of circulation, kidney and lung research group, he collaborates extensively with international institutions including Imperial College London and major US/EU healthcare networks on vaccine trials targeting cardiovascular protection in elderly patients.